Technology | December 23, 2013

AliveCor Expands eHealth Service to Android Users

alivecor aliveinsights ecg wireless remote access patient monitoring systems

December 23, 2013 — AliveCor announced Android compatibility for its AliveInsights analysis service, which launched for iOS (iPhone) users of the AliveCor Heart Monitor Nov. 18, 2013.
 
AliveInsights offers review of electrocardiograms (ECGs) directly through the AliveECG app. For a fee ranging from $2 to $12, patients  or physicians can choose to receive a technical review performed by a cardiac technician or a more in-depth clinical review from a Board-Certified Cardiologist. When symptoms arise, patients can receive expert analysis of their heart rhythm 24/7.
 
“I have used the expert analysis four to five times,” said Roland Guidry, AliveCor patient user. “My use of the cardiac technician review service eliminated the need for an appointment, since my cardiologist can review the reports from afar. My cardiologist has a lot of faith in the product and the fidelity of the tracing.”
 
“I like that the AliveInsights service doesn’t require a subscription and can be used as-needed if I see something abnormal,” said Lisa Vasquez, AliveCor patient user. “The service is priced very reasonably and having access to expert analysis on-demand gives me peace of mind especially if I’m traveling.”
 
The AliveCor Heart Monitor is the only U.S. Food and Drug Administration (FDA)-cleared mobile ECG recorder that supports both iPhone and Android smartphones. It records, displays, annotates, stores and transfers single-channel electrocardiogram (ECG) rhythms wirelessly using the free AliveECG app. With secure storage in the Cloud, patients can access their data confidentially anytime, anywhere and can grant access to their physician. The Heart Monitor is available for purchase in the United States by medical professionals and patients with prescriptions.
 
For more information: www.alivecor.com

Related Content

News | ECG

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...

Home March 06, 2026
Home
News | ECG

March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home March 04, 2026
Home
News | ECG

Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...

Home February 24, 2026
Home
News | ECG

Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...

Home February 20, 2026
Home
News | ECG

Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...

Home February 16, 2026
Home
News | ECG

Jan. 8, 2026 — AccurKardia recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the ...

Home January 15, 2026
Home
News | ECG

Jan. 13, 2026 — AliveCor has received U.S. Food and Drug Administration (FDA) clearance for the next generation of KAI ...

Home January 14, 2026
Home
News | ECG

Oct. 8, 2025 — Viz.ai recently launched Viz ACS, a new solution in the Viz Cardio Suite. Designed to unite the acute ...

Home October 09, 2025
Home
News | ECG

Aug. 14, 2025 — During HeartBeam, Inc.'s second quarter 2025 earnings conference call, the medical technology company ...

Home August 15, 2025
Home
News | ECG

July 24, 2025 — Royal Philips has announced a collaboration with Epic to integrate Philips’ suite of cardiac ambulatory ...

Home July 24, 2025
Home
Subscribe Now